NASDAQ | ETF
Biotech Acquisition Company does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
The company was incorporated in 2020 and is based in New York, New York.
Top 10 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
MNK_old | Mallinckrodt plc | Healthcare | Drug Manufacturers - Specialty & Generic | 7.38% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.91% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.43% |
BGNE | BeiGene Ltd | Healthcare | Biotechnology | 4.23% |
RTRX | Travere Therapeutics Inc | Healthcare | Biotechnology | 4.23% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.17% |
UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 4.12% |
HZNP | Horizon Pharma PLC | Healthcare | Drug Manufacturers - General | 4.07% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 4.04% |
RARE | Ultragenyx | Healthcare | Biotechnology | 4.04% |